186 related articles for article (PubMed ID: 3554163)
1. [Immunogenicity of MC Lente Novo insulin].
Rogala H; Lawecki J; Czyzyk A
Pol Arch Med Wewn; 1986 Sep; 76(3):172-6. PubMed ID: 3554163
[No Abstract] [Full Text] [Related]
2. Human insulin.
Roberts RJ
Iowa Med; 1984 Mar; 74(3):116-8. PubMed ID: 6373658
[No Abstract] [Full Text] [Related]
3. Insulin antibodies and clinical complications in diabetics treated for five years with lente or sulfated insulin.
Little JA; Lee R; Sebriakova M; Csima A
Diabetes; 1977 Oct; 26(10):980-8. PubMed ID: 561729
[No Abstract] [Full Text] [Related]
4. [The antigenicity of various new chromatographically purified depot insulin preparations].
Graber D; Fankhauser S
Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418
[TBL] [Abstract][Full Text] [Related]
5. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
[No Abstract] [Full Text] [Related]
6. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.
Bruni B; Gamba S; Regis G; Turco GL
Diabetologia; 1978 Mar; 14(3):165-9. PubMed ID: 566232
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of semisynthetic human insulin.
Rogala H; Lawecki J; Czyzyk A
Acta Med Pol; 1986; 27(1-2):45-50. PubMed ID: 3551505
[No Abstract] [Full Text] [Related]
8. Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin.
Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
Diabetologia; 1974 Jun; 10(3):233-6. PubMed ID: 4845724
[No Abstract] [Full Text] [Related]
9. Behaviour of insulin antibodies in diabetics treated with different insulins.
Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical trial with porcine monocomponent lente insulin (Monotard).
Bruni B; Bruni Bocher K; Gamba S; Giolitti A; Rittatore R; Turco GL
Panminerva Med; 1977; 19(4):247-54. PubMed ID: 593701
[No Abstract] [Full Text] [Related]
11. [Therapeutic qualities of a lente preparation of swine insulins manufactured by Pharmachem].
Andreev D; Bozadzhieva E; Pampulov L; Penchev I; Uzunova B
Vutr Boles; 1977; 16(6):59-66. PubMed ID: 341532
[TBL] [Abstract][Full Text] [Related]
12. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin.
Wajchenberg BL; Thomsen YG; Toledo e Souza IT; Germek OA
Horm Metab Res; 1986 Aug; 18(8):535-9. PubMed ID: 3758926
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial with monocomponent lente insulins. Preliminary report.
Bruni B; D'Alberto M; Osenda M; Ricci C; Turco GL
Diabetologia; 1973 Dec; 9(6):492-8. PubMed ID: 4589824
[No Abstract] [Full Text] [Related]
14. Treatment of insulin lipoatrophy with monocomponent insulin.
Teuscher A
Diabetologia; 1974 Jun; 10(3):211-4. PubMed ID: 4845721
[No Abstract] [Full Text] [Related]
15. [The study of insulin antibodies in different forms of diabetes mellitus].
Mincu I; Ionescu-Tirgovişte C; Cheţa D; Simionescu L; Mirodon Z; Vasilescu V; Bruckner I
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):421-8. PubMed ID: 44565
[No Abstract] [Full Text] [Related]
16. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin.
Piers DA; Sluiter WJ; Reitsma WD; Doorenbos H
Neth J Med; 1974; 17(4-5):234-8. PubMed ID: 4465730
[No Abstract] [Full Text] [Related]
17. [Clinical evaluation of the mono-peak porcine and bovine insulin preparations, Maxirapid and Lente].
Sroczyński J; Pietraszek F; Bresler M; Kuleszyńska G
Pol Tyg Lek; 1986 Mar; 41(11):339-42. PubMed ID: 3520515
[No Abstract] [Full Text] [Related]
18. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
[TBL] [Abstract][Full Text] [Related]
19. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
Göbel P; Kramer W; Heni F
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
[No Abstract] [Full Text] [Related]
20. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
